Koninklijke Philips (PHG) Net Income Growth (3y) (2012 - 2026)

Koninklijke Philips (PHG) Net Income Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Abbott Laboratories 157.80 Bn 151.14 Bn 6.27 Bn -6.51%
2 Stryker 115.54 Bn 112.66 Bn 3.81 Bn 7.96%
3 Medtronic 103.44 Bn 95.27 Bn 5.76 Bn -2.19%
4 Boston Scientific 72.38 Bn 71.17 Bn 3.61 Bn 62.29%
5 Edwards Lifesciences 49.76 Bn 46.09 Bn 1.29 Bn -
6 Dexcom 29.53 Bn 28.42 Bn 750.30 Mn 60.12%
7 GE HealthCare Technologies 29.51 Bn 27.44 Bn 1.98 Bn 2.38%
8 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 343.24%
9 Steris 20.69 Bn 20.27 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 17.04 Bn 16.63 Bn 1.51 Bn 0.80%

Historic Data

Download Data
DateValue
Mar 31, 2026 343.24%
Dec 31, 2025 -36.98%
Sep 30, 2025 -124.24%
Jun 30, 2025 -60.33%
Mar 31, 2025 73.01%
Dec 31, 2024 -135.46%
Sep 30, 2024 -63.41%
Jun 30, 2024 12.74%
Mar 31, 2024 -76.89%
Dec 31, 2023 -27.88%
Sep 30, 2023 -28.20%
Jun 30, 2023 -28.89%
Mar 31, 2023 -28.72%
Dec 31, 2022 33.66%
Sep 30, 2022 26.75%
Jun 30, 2022 31.85%
Mar 31, 2022 -215.41%
Dec 31, 2021 27.17%
Sep 30, 2021 163.00%
Jun 30, 2021 35.41%